依达拉奉联合PCI治疗急性ST段抬高型心肌梗死患者近期预后效果被引量：4

下载PDF

导出

摘要目的探讨在经皮冠状动脉介入治疗(PCI)中依达拉奉对ST段抬高型心肌梗死(ASTEMI)患者的治疗效果。方法选取2012年3月至2013年11月行PCI的ASTEMI患者69例,分为依达拉奉组35例和对照组34例。依达拉奉组患者在常规PCI的基础上联合依达拉奉治疗,对照组患者采用常规PCI,观察两组患者在治疗前后氧化低密度脂蛋白(ox-LDL)和C-反应蛋白(CRP)水平变化情况。结果与治疗前比较,两组患者术后ox-LDL和CRP水平均显著下降,且术后依达拉奉组ox-LDL[(397.4±98.3)μg/L]和CRP[(3.0±1.1)mg/L]水平较对照组[(701.2±103.1)μg/L、(15.8±3.7)mg/L]显著降低,差异均有统计学意义(P<0.05)。结论在行PCI术中联合依达拉奉治疗ASTEMI可以显著改善患者的近期预后。

作者康邦国

机构地区徐州市中医院

出处《现代医药卫生》 2016年第2期251-253,共3页 Journal of Modern Medicine & Health

关键词安替比林/类似物和衍生物血管成形术经腔经皮冠状动脉急性病心肌梗死依达拉奉

分类号 R541 [医药卫生—心血管疾病]

引文网络
相关文献

参考文献8

1Violaris AG, Melkert R, Herrman JP, et al. Role of angiographically iden- tifiable thrombus on long-term luminal renarrowing after coronary angio- plasty : aquantitative angiographic analysis [J]. Circulation, 1996,93 (5) :889-897.
2Ridker PM, Rifai N, Rose L,et al. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardio- vascular events[J]. N Engl J Med, 2002,347 (20) : 1557-1565.
3杨跃进,杨进刚.AHA/ACC 2009年ST段抬高心肌梗死和经皮冠状动脉介入治疗指南更新解读[J].心血管病学进展,2010,31(2):159-161. 被引量：24
4Bickel C, Rupprecht HJ, Blankenberg S, et al. Relation of markers of in- flammation (C-reactive protein,fibrinogen,von Willebrand factor,and leukocyte count) and statin therapy to long-term mortality in patients with angiographieally proven coronary artery disease[J]. Am J Cardiol,2002, 89(8) :901-908.
5Huang CH, Chang CC, Huang CS,et al. Using oxidized low-density lipo- protein autoantibodies to predict restenosis after balloon angioplasty inpatients with acute myocardial infarction [J]. PLoS One,2013,8 (10): e74726.
6Kugiyama K, Kerns SA, Morrisett JD, et al. Impairment of endothelium- dependent arterial relaxation by lysolecithin in modified low-density li- poproteins[J]. Nature, 1990,344(6262 ) : 160-162.
7L6pez-Cuenca, Manzano-Fern~mdez S, Lip GY, et al. Intedeukin-6 and high-sensitivity C-reactive protein for the prediction of outcomes in non-ST- segment elevationacute coronary syndromes[J]. Rev Esp Cardiol (Engl Ed), 2013,66(3) : 185-192.
8杨泉锋,陈国桢.C-反应蛋白对急性心肌梗死致心律失常机制影响的研究进展[J].检验医学与临床,2013,10(4):465-467. 被引量：5

二级参考文献31

1李文杰,陈次滨,卢雄.血清C-反应蛋白对急性心肌梗死患者预后的价值[J].河北医药,2005,27(1):35-36. 被引量：15
2Kushner FG, Hand M, Smith SC Jr, et al. 2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/ SCAI guidelines on percutaneous coronary intervention ( updating the 2005 guideline and 2007 focused update) a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines [ J ]. J Am Coll Cardiol1,2009 ,54 ( 23 ) :2205-2241.
3黄照河,黄显南,陆克兴,潘兴寿,蓝景生.急性心肌梗死并室性心律失常患者血清黏附分子和C反应蛋白水平变化的临床研究[J].右江医学,2007,35(5):495-497. 被引量：5
4Lowel H,Dobson A,Keil U. Coronary heart disease case fatality in four countries.A community study.The Acute Myocardial Infraction Register Team of Auckland,Augsburg,Bremen,FINMONICA,Newcastle,and Perth[J].Circulation,1993.2524-2531.
5Wilson SH,Berger PB,Mathew V. Immediate and late outcome after direct stent implantation without balloon predilation[J].Journal of the American College of Cardiology,2000.937-943.
6Amadou A,Nawrockt A,Best-Belpomme M. Arachidonic acid mediates dual effect of TNF-αlpha Ca2+ transients and contraction of adult ratcardiomyocytes[J].Am J Physiol Cell Physol,2002,(06):1339-1347.
7Vandervelde S,van Amerongen MJ,Tio RA. Increased inflammatory response and neovascularization in reperfused vs nonreperfused murine myocardial infarction[J].Cardiovascular Pathology,2006,(02):83-90.
8Suzuki K,Murtuza B,Smolenski RT. Overexpression of interleukin-1 receptor antagonist provides cardioprotection against ischemia-reperfusion injury associated with reduction in apoptosis[J].Circulation,2001,(12 Suppl 1):1308-1313.
9ST John Sutton M,Lee D,Rouleau JL. Left ventricular remodeling and ventricular arrhythmias after myocardial infraction[J].Circulation,2003,(20):2577-2852.
10Lu X,Hamilton JA,Shen J. Role of tumor necrosis factor-αin myocardial dysfunction and apoptosis during hindlimb ischemia and reperfusion[J].Critical Care Medicine,2006,(02):484-491.